Learn More
Siemens Healthineers PFA-100 Instrument (US/CA)
The PFA-100™ System measures the complex process of primary hemostasis and aids in the rapid detection of platelet dysfunction. It is the first commercially available in vitro testing system to incorporate high-shear flow in which the process of platelet adhesion and aggregation following a vascular injury is simulated in-vitro.
Supplier: Siemens Healthineers 10459298
Description
The PFA-100™ System provides automated assessment for inherited, acquired, or drug-induced platelet dysfunction.
- Helps detect inherited, acquired and drug-induced platelet dysfunction
- Screening test for patients with impaired primary hemostasis, such as von Willebrand disease
- Verifies efficacy of desmopressin acetate (DDAVP) therapy in pre-surgical patients
- Assesses the platelet dysfunction due to the effect of Aspirin
- Evaluates platelet dysfunction in children over 1 year of age
- Evaluates platelet dysfunction in multiple clinical settings, such as presurgical screening, high-risk pregnancy and menorrhagia

Specifications
Hemostasis System | |
Citrated Whole Blood | |
Single Test: Col/EPI or Col/ADP: 6 tests/hour; Duplicate Test: Col/EPI or Col/ADP: 10 tests/hour | |
High-shear force dynamic flow system |
Safety and Handling
Your input is important to us. Please complete this form to provide feedback related to the content on this product.